A group of biotech and investment professionals have collaborated to establish the $20 million venture capital firm Translational Accelerator LLC that will invest in early-stage bioscience firms and boost economic progress in Arizona. The firm plans to invest $500,000 to $2 million of its funds in the development of preventive treatments for cancer and diseases related to the central nervous system.

Related Summaries